针刀血管减排术防治心脑血管疾病的临床疗效(1)
[摘要] 目的 观察针刀血管减排术防治心脑血管疾病的临床疗效。 方法 选取2014年1月～2015年1月北京世华针刀中医医院收治的心脑血管疾病及高风险患者109例作为研究对象，按照随机数字表法将患者分为两组，治疗组(55例)和对照组(54例)。对照组给予西医基础治疗，治疗组在对照组的基础上采用针刀血管减排术进行治疗。观察两组患者临床疗效和临床症状改善情况，并记录两组患者不良反应发生情况。 结果 对照组显效34例，有效14例，总有效率为88.89%；治疗组显效38例，有效16例，总有效率为98.18%。两组总有效率比较差异有统计学意义(P < 0.05)。两组治疗前临床症状比较差异无统计学意义(P > 0.05)，两组组内治疗后1、2个月症状消失率比较差异无统计学意义(P > 0.05)，但治疗组治疗后1、2个月头晕、头痛和头胀消失率[73.81%(31/42)、88.10%(37/42)]、视力模糊消失率[72.73%(24/33)、87.88%(29/33)]、耳鸣消失率[66.67%(14/21)、95.24%(20/21)]以及胸闷、心慌和气短消失率[78.95%(15/19)、94.74%(18/19)]均明显高于对照组[61.54%(24/39)、79.49%(31/39)； 59.26%(16/27)、77.78%(21/27)；64.00%(16/25)、84.00%(21/25)；68.18%(15/22)、86.36%(19/22)]，差异均有统计学意义(均P < 0.05)。两组均无严重不良反应发生。 结论 针刀血管减排术在一级防治心脑血管疾病方面效果较好，能有效减轻和改善患者临床症状，降低心脑血管疾病的发病风险，且不增加不良反应，值得临床推广应用。
[关键词] 针刀血管减排术；心脑血管疾病；临床疗效
[中图分类号] R541.4 [文献标识码] A [文章编号] 1673-7210(2015)06(b)-0165-05
Clinical effect of acupotomology vascular reduction technique in prevention and treatment of cardiovascular and cerebrovascular diseases
GE Hengjun JIANG Mei
Beijing Shihua Acupotomology & Chinese Medicine Hospital， Beijing 100021， China
[Abstract] Objective To observe the clinical effect of acupotomology vascular reduction technique in prevention and treatment of cardiovascular and cerebrovascular diseases. Methods 109 cases of patients with cardiovascular and cerebrovascular diseases and high-risk ones admitted to Beijing Shihua Acupotomology & Chinese Medicine Hospital from January 2014 to January 2015 were selected as research objects， they were divided into two groups according to the random number table， treatment group (55 cases) and control group (54 cases). The control group was given western basic therapy， on basis of which， the treatment group was given acupotomology vascular reduction technique. The clinical effect and improvement of clinical symptoms were observed， and the conditions of adverse reactions of the two groups were recorded. Results In control group， there were 34 cases of excellent， 14 cases of effective， the total effective rate was 88.89%； in the treatment group， there were 38 cases of excellent， 16 cases of effective， the total effective rate was 98.18%. The total effective rate between the two groups had a statistically significant difference (P < 0.05). The clinical symptoms before treatment of the two groups had no statistically significant difference (P > 0.05). The symptoms disappear rate after treatment for 1， 2 months for intra-group comparison in the two groups had no statistically significant differences (P > 0.05). After treatment for 1， 2 months， in treatment group， the disappear rates of dizziness， headache and head bilges [73.81% (31/42)， 88.10% (37/42)]， blurring of vision [72.73% (24/33)， 87.88% (29/33)]， tinnitus [66.67% (14/21)， 95.24% (20/21)] and chest distress， palpitation and short of breath [78.95% (15/19)， 94.74% (18/19)] were all significantly higher than those of control group [61.54% (24/39)， 79.49% (31/39)； 59.26% (16/27)， 77.78% (21/27)； 64.00% (16/25)， 84.00% (21/25)； 68.18% (15/22)， 86.36% (19/22)]， the differences were all statistically significant (all P < 0.05). Both groups had no serious adverse reactions. Conclusion The acupotomology vascular reduction technique has a good effect for primary prevention and treatment of cardiovascular and cerebrovascular diseases， which can reduce and improve clinical symptoms， decrease the risk of cardiovascular and cerebrovascular diseases， without increasing adverse reactions， it is worthy of clinical promotion and application. (葛恒君 蒋梅)
[关键词] 针刀血管减排术；心脑血管疾病；临床疗效
[中图分类号] R541.4 [文献标识码] A [文章编号] 1673-7210(2015)06(b)-0165-05
Clinical effect of acupotomology vascular reduction technique in prevention and treatment of cardiovascular and cerebrovascular diseases
GE Hengjun JIANG Mei
Beijing Shihua Acupotomology & Chinese Medicine Hospital， Beijing 100021， China
[Abstract] Objective To observe the clinical effect of acupotomology vascular reduction technique in prevention and treatment of cardiovascular and cerebrovascular diseases. Methods 109 cases of patients with cardiovascular and cerebrovascular diseases and high-risk ones admitted to Beijing Shihua Acupotomology & Chinese Medicine Hospital from January 2014 to January 2015 were selected as research objects， they were divided into two groups according to the random number table， treatment group (55 cases) and control group (54 cases). The control group was given western basic therapy， on basis of which， the treatment group was given acupotomology vascular reduction technique. The clinical effect and improvement of clinical symptoms were observed， and the conditions of adverse reactions of the two groups were recorded. Results In control group， there were 34 cases of excellent， 14 cases of effective， the total effective rate was 88.89%； in the treatment group， there were 38 cases of excellent， 16 cases of effective， the total effective rate was 98.18%. The total effective rate between the two groups had a statistically significant difference (P < 0.05). The clinical symptoms before treatment of the two groups had no statistically significant difference (P > 0.05). The symptoms disappear rate after treatment for 1， 2 months for intra-group comparison in the two groups had no statistically significant differences (P > 0.05). After treatment for 1， 2 months， in treatment group， the disappear rates of dizziness， headache and head bilges [73.81% (31/42)， 88.10% (37/42)]， blurring of vision [72.73% (24/33)， 87.88% (29/33)]， tinnitus [66.67% (14/21)， 95.24% (20/21)] and chest distress， palpitation and short of breath [78.95% (15/19)， 94.74% (18/19)] were all significantly higher than those of control group [61.54% (24/39)， 79.49% (31/39)； 59.26% (16/27)， 77.78% (21/27)； 64.00% (16/25)， 84.00% (21/25)； 68.18% (15/22)， 86.36% (19/22)]， the differences were all statistically significant (all P < 0.05). Both groups had no serious adverse reactions. Conclusion The acupotomology vascular reduction technique has a good effect for primary prevention and treatment of cardiovascular and cerebrovascular diseases， which can reduce and improve clinical symptoms， decrease the risk of cardiovascular and cerebrovascular diseases， without increasing adverse reactions， it is worthy of clinical promotion and application. (葛恒君 蒋梅)